|
| | Publication Year | Title | Author(s) |
| 1 | 31-Dec-2020 | Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival. | Chia, Puey Ling ; Parakh, Sagun ; Russell, Prudence; Gan, Hui K ; Asadi, Khashayar ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Liu, Zhanqi; Thapa, Bibhusal ; Scott, Fiona E; Scott, Andrew M ; John, Thomas |
| 2 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 3 | Apr-2019 | Mesenchyme to epithelial transition protein expression, gene copy number and clinical outcome in a large non-small cell lung cancer surgical cohort. | Rivalland, Gareth; Mitchell, Paul L R ; Murone, Carmel ; Asadi, Khashayer; Morey, Adrienne L; Starmans, Maud; Boutros, Paul C; Walkiewicz, Marzena; Solomon, Benjamin; Wright, Gavin; Knight, Simon; John, Thomas |
| 4 | 27-Jul-2018 | Development of monoclonal anti-PDGF-CC antibodies as tools for investigating human tissue expression and for blocking PDGF-CC induced PDGFRα signalling in vivo. | Li, Hong; Zeitelhofer, Manuel; Nilsson, Ingrid; Liu, Xicong; Allan, Laura C ; Gloria, Benjamin; Perani, Angelo; Murone, Carmel ; Catimel, Bruno; Neville, A Munro; Scott, Fiona E; Scott, Andrew M ; Eriksson, Ulf |
| 5 | Apr-2018 | Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study. | Lau, David K ; Tay, Rebecca Y; Yeung, Yvonne H ; Chionh, Fiona; Mooi, Jennifer; Murone, Carmel ; Skrinos, Effie; Price, Timothy J; Mariadason, John M; Tebbutt, Niall C |
| 6 | 29-Jan-2018 | DUSP5 is methylated in CIMP-high colorectal cancer but is not a major regulator of intestinal cell proliferation and tumorigenesis. | Tögel, Lars; Nightingale, Rebecca; Wu, Rui; Chüeh, Anderly C; Al-Obaidi, Sheren; Luk, Ian; Dávalos-Salas, Mercedes; Chionh, Fiona; Murone, Carmel ; Buchanan, Daniel D; Chatterton, Zac; Sieber, Oliver M; Arango, Diego; Tebbutt, Niall C ; Williams, David; Dhillon, Amardeep S; Mariadason, John M |
| 7 | 22-Apr-2017 | PD-L1 and tumor infiltrating lymphocytes as prognostic markers in resected NSCLC | Ameratunga, Malaka; Asadi, Khashayar ; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Knight, Simon; Mitchell, Paul L R ; Boutros, Paul; John, Thomas |
| 8 | 2017 | The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma. | Thapa, Bibhusal ; Salcedo, Adriana; Lin, Xihui; Walkiewicz, Marzena; Murone, Carmel ; Ameratunga, Malaka; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon; Mitchell, Paul L R ; Watkins, D Neil; Boutros, Paul C; John, Thomas |
| 9 | Dec-2016 | Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma. | Thapa, Bibhusal ; Walkiewicz, Marzena; Murone, Carmel ; Asadi, Khashayar ; Deb, Siddhartha; Barnett, Stephen A ; Knight, Simon R ; Mitchell, Paul L R ; Liew, Danny; Watkins, D Neil; John, Thomas |
| 10 | 18-Oct-2016 | Digital PCR of genomic rearrangements for monitoring circulating tumour DNA | Do, Hongdo; Cameron, Daniel; Molania, Ramyar; Thapa, Bibhusal ; Rivall, Gareth; Mitchell, Paul L R ; Murone, Carmel ; John, Thomas ; Papenfuss, Anthony; Dobrovic, Alexander |
| 11 | 24-Jul-2016 | Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers | Lau, Lawrence F ; Murone, Carmel ; Williams, David S ; Standish, Richard; Lee, Sze Ting ; Christophi, Christopher ; Scott, Andrew M ; Muralidharan, Vijayaragavan |
| 12 | 10-Nov-2015 | Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways | Greening, David W; Lee, Sze Ting ; Ji, Hong; Simpson, Richard J; Rigopoulos, Angela; Murone, Carmel ; Fang, Catherine; Gong, Sylvia J; O’Keefe, Graeme J; Scott, Andrew M |
| 13 | 24-Nov-2014 | Hypoxia-controlled EphA3 marks a human endometrium-derived multipotent mesenchymal stromal cell that supports vascular growth. | To, Catherine; Farnsworth, Rae H; Vail, Mary E; Chheang, Chanly; Gargett, Caroline E; Murone, Carmel ; Llerena, Carmen; Major, Andrew T; Scott, Andrew M ; Janes, Peter W; Lackmann, Martin |
| 14 | 30-May-2014 | Quantitative intratumoural microdistribution and kinetics of (131)I-huA33 antibody in patients with colorectal carcinoma. | Ciprotti, Marika; Chong, Geoffrey ; Gan, Hui K ; Chan, Anthony; Murone, Carmel ; MacGregor, Duncan; Lee, Fook-Thean; Johns, Terrance G; Heath, Joan K; Ernst, Matthias; Burgess, Antony W; Scott, Andrew M |
| 15 | 26-Feb-2014 | A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinoma. | Do, Hongdo; Wong, Nicholas C; Murone, Carmel ; John, Thomas ; Solomon, Benjamin J; Mitchell, Paul L R ; Dobrovic, Alexander |
| 16 | 13-Oct-2009 | Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. | Herbertson, Rebecca A; Tebbutt, Niall C ; Lee, Fook-Thean; MacFarlane, David J; Chappell, Bridget; Micallef, Noel; Lee, Sze-Ting; Saunder, Timothy; Hopkins, Wendie; Smyth, Fiona E; Wyld, David K; Bellen, John; Sonnichsen, Daryl S; Brechbiel, Martin W; Murone, Carmel ; Scott, Andrew M |
| 17 | 1-Jun-2007 | A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. | Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J |
| 18 | 1-Dec-2006 | Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET. | Cherk, Martin H; Foo, Serene S; Poon, Aurora M T ; Knight, Simon R ; Murone, Carmel ; Papenfuss, Anthony T; Sachinidis, John I; Saunder, Timothy H C; O'Keefe, Graeme J; Scott, Andrew M |
| 19 | 1-Mar-2006 | Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies. | Cher, Lawrence M ; Murone, Carmel ; Lawrentschuk, Nathan; Ramdave, Shanker; Papenfuss, Anthony; Hannah, Anthony; O'Keefe, Graeme J; Sachinidis, John I; Berlangieri, Salvatore U ; Fabinyi, Gavin C ; Scott, Andrew M |
| 20 | 1-Sep-2005 | Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. | Perera, Rushika M; Narita, Yoshitaka; Furnari, Frank B; Gan, Hui K ; Murone, Carmel ; Ahlkvist, Marika; Luwor, Rodney B; Burgess, Antony W; Stockert, Elisabeth; Jungbluth, Achim A; Old, Lloyd J; Cavenee, Webster K; Scott, Andrew M ; Johns, Terrance G |
Loading...
2
0
5
0
false